Earnings Summary

Twist Bioscience Corp’s revenue jumped 31.81% since last year same period to $71.5Mn in the Q4 2023. On a quarterly growth basis, Twist Bioscience Corp has generated 6.8% jump in its revenue since last 3-months.

Twist Bioscience Corp’s net profit fell -2.83% since last year same period to $-43.01Mn in the Q4 2023. On a quarterly growth basis, Twist Bioscience Corp has generated 7% jump in its net profits since last 3-months.

Twist Bioscience Corp’s net profit margin jumped 21.99% since last year same period to -60.15% in the Q4 2023. On a quarterly growth basis, Twist Bioscience Corp has generated 12.92% jump in its net profit margins since last 3-months.

Twist Bioscience Corp’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a -5.13% fall from last quarter’s estimates.

Twist Bioscience Corp’s earning per share (EPS) estimates for the current year stand at -0.82.

Twist Bioscience Corp’s earning per share (EPS) fell -1.35% since last year same period to -0.75 in the Q4 2023. This indicates that the Twist Bioscience Corp has generated -1.35% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Twist Bioscience Corp’s return on assets (ROA) stands at -0.16.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Twist Bioscience Corp’s return on equity (ROE) stands at -0.31.